Locally advanced cervical cancer: What is the standard of care?

Current Opinion in Oncology

Volumn 22, Issue 5, 2010, Pages 503-512

  Al Mansour, Zeina ^a   Verschraegen, Claire ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

concurrent chemoradiation; locally advanced cervical cancer; neoadjuvant chemotherapy

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC METAL COMPLEX; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; GEFITINIB; GEMCITABINE; HYDROXYUREA; IFOSFAMIDE; IMATINIB; IRINOTECAN; MITOMYCIN; NEDAPLATIN; OXALIPLATIN; PACLITAXEL; PLATINUM; TOPOTECAN; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADD ON THERAPY; ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG DOSE ESCALATION; FEMALE FERTILITY; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PREGNANCY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RECURRENT DISEASE; REVIEW; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; VACCINATION;

CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; NEOADJUVANT THERAPY; UTERINE CERVICAL NEOPLASMS;

EID: 77955414494     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32833af426     Document Type: Review

References (124)

1. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in incidence of cervical cancer. II: Squamous-cell carcinoma. Int J Cancer 2000; 86:429-435.
2. Munoz N, Kjaer SK, Sigurdsson K, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 2010; 102:325-339.
3. Monk BJ, Sill MW, McMeekin DS, et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009; 28:4649-4655.
4. Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, editors. Cancer management: a multidisciplinary approach. 11th ed. CMP Healthcare Media LLC; 2008.
5. Rotman M, Sedlis A, Piedmonte MR, et al. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2006; 65:169-176.
6. Delgado G, Bundy B, Zaino R, et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990; 38:352-357.
7. Devita VT, Hellman S, Rosenberg SA, et al., editors. Cancer: principles and practice of oncology. 8th ed. Philadelphia, Phennsylvania: Lippincott Williams & Wilkins; 2007.
8. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340:1154-1161.
9. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17:1339-1348.
10. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radio-therapyand chemotherapy for locally advanced cervical cancer.NEnglJMed 1999; 340:1144-1153.
11. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340:1137-1143.
12. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18:1606-1613.
13. Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2001:CD002225.
14. Lukka H, Hirte H, Fyles A, et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis. Clin Oncol (R Coll Radiol) 2002; 14:203-212.
15. Nagy V, Coza O, Ordeanu C, et al. Radiotherapy versus concurrent 5-day cisplatin and radiotherapy in locally advanced cervical carcinoma. Long-term results of a phase III randomized trial. Strahlenther Onkol 2009; 185:177-183.
16. Niibe Y, Tsunoda S, Jobo T, et al. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)-initial analysis. Eur J Gynaecol Oncol 2008; 29:222-224.
17. Yokoyama Y, Takano T, Nakahara K, et al. A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study. Oncol Rep 2008; 19:1551-1556.
18. Kodama J,Takemoto M, Seki N, et al. Phase I study of weekly nedaplatin and concurrent pelvic radiotherapy as adjuvant therapy after radical surgery for cervical cancer. Int J Gynecol Cancer 2008; 18:1037-1041.
19. Kodama J, Takemoto M, Seki N, et al. Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix. Int J Gynecol Cancer 2008; 18:1300-1304.
20. Alvarez EA, Wolfson AH, Pearson JM, et al. A phase I study of docetaxel as a radio-sensitizerfor locally advanced squamous cell cervical cancer. Gynecol Oncol 2009; 113:195-199.
21. Domingo E, Lorvidhaya V, de Los Reyes R, et al. Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results. Oncologist 2009; 14:828-834.
22. Bhatt ML, Matin A, Srivastava M, et al. Evaluation of gemcitabine versus cisplatinum as an adjuctto radiotherapy in locally advanced carcinoma of the cervix. In: ASCO Annual Meeting; 2007. p. 16012.
23. Rose PG, Degeest K, McMeekin S, Fusco N. A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2007; 107:274-279.
24. Gonzalez-Cortijo L, Carballo N, Gonzalez-Martin A, et al. Novel chemotherapy approaches in chemoradiation protocols. Gynecol Oncol 2008; 110 (3 Suppl 2):S45-S48.
25. Umanzor J, Aguiluz M, Pineda C, et al. Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial. Gynecol Oncol 2006; 100:70-75.
26. Movva S, Rodriguez L, Arias-Pulido H, Verschraegen C. Novel chemotherapy approaches for cervical cancer. Cancer 2009; 115:3166-3180.
27. Zarba JJ, JaremtchukAV, Gonzalez Jazey P, et al. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma. Ann Oncol 2003; 14:1285-1290.
28. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez A, et al. Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma. Am J Clin Oncol 2003; 26:22-25.
29. Pattaranutaporn P, Thirapakawong C, Chansilpa Y, et al. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma. Gynecol Oncol 2001; 81:404-407.
30. Lissoni AA, Colombo N, Pellegrino A, et al. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol 2009; 20:660-665.
31. Walker JL, Morrison A, DiSilvestro P, von Gruenigen VE. A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the paraaortic lymph nodes: a Gynecologic Oncology Group study. Gynecol Oncol 2009; 112:78-84.
32. Prasad E, Viswanathan PN, Rangad VF, et al. Maximum tolerated dose and early response: results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix. Clin Oncol (RColl Radiol) 2009; 21:488-493.
33. Umayahara K, Takeshima N, Nose T, et al. Phase I study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma in Japanese women. Int J Gynecol Cancer 2009; 19:723-727.
34. Addeo D, Becker S, Muggia F, Formenti S. Concurrent radiotherapy, paclitaxel and dose-escalating carboplatin in the treatment of cervical cancer: a phase I study. Anticancer Res 2008; 28:4.
35. Kodaira T, Fuwa N, Nakanishi T, et al. Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinoma. Int J Radiat Oncol Biol Phys 2009; 73:251-258.
36. Sol ES, Lee TS, Koh SB, et al. Comparison of concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil versus cisplatin plus paclitaxel in patients with locally advanced cervical carcinoma. J Gynecol Oncol 2009; 20:28-34.
37. Sukhaboon J, Porapakkhan P, Penpattanagul S. Randomized comparison of fluorouracil plus cisplatin vs. cisplatin as an adjunct to radiation therapy in stage IIB-IVA squamous cell carcinoma of the cervix: pilot study. J Med Assoc Thai 2009; 92:1072-1076.
38. Kim YS, Shin SS, Nam JH, et al. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer. Gynecol Oncol 2008; 108:195-200.
39. Bae JH, LeeSJ, Lee A, et al. Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer. Gynecol Oncol 2008; 111:444-448.
40. Takano M, Kato M, Yoshikawa T, et al. Clinical significance of UDP-glucur-onosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: a prospective multiinstitu-tional study. Oncology 2009; 76:315-321.
41. Yamamoto K, Kokawa K, Umesaki N, et al. Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study. Oncol Rep 2009; 21:1005-1009.
42. Gatcliffe TA, Tewari KS, Shah A, et al. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer. Gynecol Oncol 2009; 112:85-89.
43. Kurtz JE, Hardy-Bessard AC, Deslandres M, et al. Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: a phase II GINECO trial. Gynecol Oncol 2009; 113:16-20.
44. Zeng SY, Li LY, Shu KY, et al. Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma. Ai Zheng 2008; 27:942-946.
45. Nogueira-Rodrigues A, doCarmoCC, ViegasC, et al. Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer. Clin Cancer Res 2008; 14:6324-6329.
46. FerreiraCG, ErlicF, CarmoCC, et al. Erlotinib (E) combined with cisplatin (C) and radiotherapy (RT) for patients with locally advanced squamous cell cervical cancer: a phase II trial. J Clin Oncol 2008; 26:5511.
47. Kummel S, HeideckeH, Brock B, et al. Imatinib: a possible therapeutic option for cervical carcinoma-results of a preclinical phase I study. Gynakol Geburtshilfliche Rundsch 2008; 48:94-100.
48. Goncalves A, Fabbro M, Lhomme C, et al. A phase II trial to evaluate gefitinib as second-or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer. Gynecol Oncol 2008; 108:42-46.
49. Kamnerdsupaphon P, Chitapanarux I, Sukthomya V, Lorvidhaya V. The 50-month results of the four nonplatinum concurrent chemoradiation regimens for locally advanced cervical cancer. In: ASCO Annual Meeting 2007. J Clin Oncol 2007. p. 5540.
50. Kokawa K, Umesaki N, Yamamoto K, et al. Phase I study of irinotecan combined with mitomycin-C and 5-fluorouracil for gynecological malignancies: the JGOG study. Anticancer Res 2008; 28:2933-2939.
51. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-Analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 2003; 39:2470-2486.
52. Chen H, Liang C, Zhang L, et al. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study. Gynecol Oncol 2008; 110:308-315.
53. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, et al. Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies. Ann Oncol 2002; 13:1212-1219.
54. Modarress M, Maghami FQ, Golnavaz M, et al. Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB-IIB bulky cervical cancer and with tumor diameter greater than 4cm. Int J Gynecol Cancer 2005; 15:483-488.
55. Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 2002; 20:179-188.
56. Benedetti-Panici PL, Zullo MA, Muzii L, et al. The role of neoadjuvant chemotherapy followed by radical surgery in the treatment of locally advanced cervical cancer. Eur J Gynaecol Oncol 2003; 24:467-470.
57. Benedetti Panici P, Bellati F, Manci N, et al. Neoadjuvant chemotherapy followed by radical surgery in patients affected by FIGO stage IVA cervical cancer. Ann Surg Oncol 2007; 14:2643-2648.
58. Termrungruanglert W, Tresukosol D, Vasuratna A, et al. Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2. Gynecol Oncol 2005; 97:576-581.
59. Eddy GL, Manetta A, Alvarez RD, et al. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lym-phadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. Gynecol Oncol 1995; 57:412-416.
60. Eddy GL, Bundy BN, Creasman WT, et al. Treatment of ('bulky') stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol 2007; 106:362-369.
61. Chang TC, Lai CH, Hong JH, et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol 2000; 18:1740-1747.
62. Benedetti-Panici P, Greggi S, Scambia G, et al. Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer 1998; 34:341-346.
63. Chiara S, Bruzzone M, Merlini L, et al. Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group). Am J Clin Oncol 1994; 17:294-297.
64. Leborgne F, Leborgne JH, Doldan R, et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys 1997; 37:343-350.
65. Souhami L, Gil RA, Allan SE, et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 1991; 9:970-977.
66. Sundfor K, Trope CG, Hogberg T, et al. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Cancer 1996; 77:2371-2378.
67. Tattersall MH, Ramirez C, Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Cancer 1992; 2:244-251.
68. Tattersall MH, Lorvidhaya V, Vootiprux V, et al. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association. J Clin Oncol 1995; 13:444-451.
69. Herod J, Burton A, Buxton J, et al. A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix. Ann Oncol 2000; 11:1175-1181.
70. Lacava JA, Leone BA, Machiavelli M, et al. Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma. J Clin Oncol 1997; 15:604-609.
71. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27:131-146.
72. Loizzi V, Cormio G, Vicino M, Selvaggi L. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer. Gynecol Obstet Invest 2008; 65:96-103.
73. Shueng PW, Hsu WL, Jen YM, et al. Neoadjuvant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 1998; 40:889-896.
74. Rew DA, Wilson GD. Cell production rates in human tissues and tumours and their significance. Part 1: An introduction to the techniques of measurement and their limitations. Eur J Surg Oncol 2000; 26:227-238.
75. Bolger BS, Symonds RP, Stanton PD, et al. Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate. Br J Cancer 1996; 74:1223-1226
76. Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA). Neoadjuvant chemotherapy for locally advanced cervix cancer. Cochrane Database Syst Rev 2004:CD001 774.
77. Duenas-Gonzalez A, Zarba JJ, Alcedo JC, et al. A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol 2009; 27:CRA5507.
78. Nugent EK, Case AS, Hoff JT, et al. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. Gynecol Oncol 2010; 116:438-441.
79. Committee on Practice Bulletins-Gynecology. ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas, number 35, May 2002. Obstet Gynecol 2002; 99(5 Pt 1):855-867.
80. Schorge JO, Schaffer JI, Halvorson LM, et al. Cervical cancer. In: Williams Gynecology; 2008.
81. Cosin JA, Fowler JM, Chen MD, et al. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 1998; 82:2241-2248.
82. Hacker NF, Wain GV, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995; 5:250-256.
83. Kupets R, Thomas GM, Covens A. Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecol Oncol 2002; 87:163-170.
84. Marnitz S, Kohler C, Roth C, et al. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol 2005; 99:536-544.
85. Leblanc E, Narducci F, FrumovitzM, et al. Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol 2007; 105:304-311.
86. Houvenaeghel G, Lelievre L, Rigouard AL, et al. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol Oncol 2006; 102:74-79.
87. Gold MA, Tian C, Whitney CW, et al. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer 2008; 112:1954-1963.
88. Lai CH, Yen TC, Ng KK. Surgical and radiologic staging of cervical cancer. Curr Opin Obstet Gynecol 2010; 22:15-20.
89. Lai CH, Huang KG, Hong JH, et al. Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol 2003; 89:160-167.
90. Coleman RL, Ramirez PT, Slomovitz BM, Levenback C. Laparoscopic extraperitoneal para-aortic lymphadenectomy in pateints with LACC: histopathologic findings and correlation with PET-CT imaging studies. J Clin Oncol, 2006 ASCO Annual Meeting Proceedings Part 1 2006; 24 (18S):5014.
91. Vigliotti AP, Wen BC, Hussey DH, et al. Extended field irradiation for carcinoma of the uterine cervix with positive periaortic nodes. Int J Radiat Oncol Biol Phys 1992; 23:501-509.
92. Sonoda Y, Leblanc E, Querleu D, et al. Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach. Gynecol Oncol 2003; 91:326-331.
93. Lecuru F, Bats A, Mathevet P, et al. Sentinel lymph node biopsy for early cervical cancer. Results of a diagnostic, prospective, multicenter study. J Clin Oncol 2008; 26:11012.
94. Vidal-Sicart S, Domenech B, Lujan B, et al. Sentinel node in gynaecological cancers. Our experience. Rev Esp Med Nucl 2009; 28:221-228.
95. Gortzak-Uzan L, Jimenez W, Nofech-Mozes S, et al. Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? Gynecol Oncol 2010; 116:28-32.
96. Lousquy R, Delpech Y, Barranger E. Role of sentinel node biopsy in early-stage cervical cancer in the therapeutic strategy. Gynecol Obstet Fertil 2009; 37:827-833.
97. Pazin V, Dragojevic S, Mikovic Z, et al. The value of sentinel lymphadenectomy in radical operative treatment of cervical cancer. Vojnosanit Pregl 2009; 66:539-543.
98. Mathevet P. Surgical lymph-node evaluation in cervical cancer. Cancer Radiother 2009; 13:499-502.
99. Cibula D, Kuzel D, Slama J, et al. Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer. Gynecol Oncol 2009; 115:46-50.
100. Oonk MH, van de Nieuwenhof HP, de Hullu JA, van Der Zee AG. The role of sentinel node biopsy in gynecological cancer: a review. Curr Opin Oncol 2009; 21:425-432.
101. Okamoto S, Niikura H, Yoshinaga K, et al. Detection of micrometastases in cervical cancer with a system that evaluates both sentinel and nonsentinel lymph nodes. Int J Gynecol Cancer 2009; 19:708-711.
102. Zarganis P, Kondi-Pafiti A, Arapantoni-Dadioti P, et al. The sentinel node in cervical cancer patients: role of tumor size and invasion of lymphatic vascular space. In Vivo 2009; 23:469-473.
103. Lecuru F, Bats A, Mathevet P, et al. Impact of sentinel lymph node biopsy on staging of early cervical cancer: results of a prospective, multicenter study. J Clin Oncol 2009; 27:CRA5506.
104. Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. Pelvic lymph node F-1 8 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer. Cancer 2010;116:1469-1475.
105. Kidd EA, Siegel BA, Dehdashti F, et al. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2009. [Epub ahead of print].
106. Vincens C, Dupaigne D, de Tayrac R, Mares P. Management of pregnant women with advanced cervical cancer. Gynecol Obstet Fertil 2008; 36:365-372.
107. Sadler L, Sykes P. How little is known about cervical cancer in pregnancy? Ann Oncol 2005; 16:341-343.
108. Nowak-Markwitz E, Spaczynski M. Carcinoma of the uterine cervix during pregnancy. Ginekol Pol 2007; 78:727-732.
109. Edelmann DZ, Anteby SO. Neoadjuvant chemotherapy for locally advanced cervical cancer: where does it stand? A review. Obstet Gynecol Surv 1996; 51:305-313.
110. Sorosky JI, Sood AK, Buekers TE. The use of chemotherapeutic agents during pregnancy. Obstet Gynecol Clin North Am 1997; 24:591-599.
111. Newton M. Radical hysterectomy or radiotherapy for stage I cervical cancer. A prospective comparison with 5 and 10 years follow-up. Am J Obstet Gynecol 1975; 123:535-542.
112. Morley GW, Seski JC. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 1976; 126:785-798.
113. Giacalone PL, Laffargue F, Benos P, et al. Cis-platinum neoadjuvant chemotherapy in a pregnant woman with invasive carcinoma of the uterine cervix. Br J Obstet Gynaecol 1996; 103:932-934.
114. Lai CH, Hsueh S, Chang TC, et al. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 1997; 64:456-462.
115. Tewari K, Cappuccini F, Gambino A, et al. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases andreviewofissues specifictothemanagementofcervicalcarcinoma in pregnancy including planned delayoftherapy. Cancer 1998; 82:1529-1534.
116. Marana HR, de Andrade JM, da Silva Mathes AC, et al. Chemotherapy in the treatment of locally advanced cervical cancer and pregnancy. Gynecol Oncol 2001; 80:272-274.
117. Caluwaerts S, Van Calsteren K, Mertens L, et al. Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature. Int J Gynecol Cancer 2006; 16:905-908.
118. Shepherd JH. Challenging dogma: radical conservation surgery for early stage cervical cancer in order to retain fertility. Ann R Coll Surg Engl 2009; 91:181-187.
119. Shepherd JH. Uterus-conserving surgery for invasive cervical cancer. Best Pract Res Clin Obstet Gynaecol 2005; 19:577-590.
120. Plante M, Renaud MC, Hoskins IA, Roy M. Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol Oncol 2005; 98:3-10.
121. Maneo A, Mangioni C. Re: neoadjuvant chemotheraphy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer. Gynecol Oncol 2006; 103:763-764; author reply 764-765.
122. Leitao MM Jr, White P, Cracchiolo B. Cervical cancer in patients infected with the human immunodeficiency virus. Cancer 2008; 112:2683-2689.
123. Chuang P, Tsai CM. Exploring the issue of cervical cancer prevention and control in women living with HIV/AIDS. Hu Li Za Zhi 2010; 57: 71-76.
124. Shrivastava SK, Engineer R, Rajadhyaksha S, Dinshaw KA. HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome. Radiother Oncol 2005; 74:31-35